I
Inhibikase Therapeutics, Inc. (IKT)
NCM – Real Time Price. Currency in USD
1.68
+0.05 (3.07%)
At close: Mar 27, 2026, 4:00 PM EDT
1.72
+0.04 (2.38%)
After-hours: Mar 27, 2026, 7:03 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
1.68
+0.05 (3.07%)
At close: Mar 27, 2026, 4:00 PM EDT
1.72
+0.04 (2.38%)
After-hours: Mar 27, 2026, 7:03 PM EDT
This stock has a consensus price target of $6.00 based on the ratings of 6 analysts. The high is $8.00 and the low is $4.00.
| Target | Lowest Price Target | Consensus Price Target | Highest Price Target |
|---|---|---|---|
| Price | $ 4 | $ 6 | $ 8 |
| Change | 138.10% | 257.14% | 376.19% |
| Date | Upside/Downside | Analyst Firm | Price Target | Rating Change | Rating |
|---|---|---|---|---|---|
| 2026-03-04 | 138.1% | Ladenburg Thalmann | $4 | Initiates Coverage On | Buy |
| 2026-01-21 | 257.14% | B of A Securities | $6 | Initiates Coverage On | Buy |
| 2025-12-26 | 376.19% | HC Wainwright & Co. | $8 | Assumes | Buy |
| 2025-12-11 | 138.1% | Cantor Fitzgerald | $4 | Initiates Coverage On | Overweight |
| 2025-03-28 | — | HC Wainwright & Co. | — | Reiterates | Neutral |